Table 1.
Native peptides and heteroclitic variants cited.
| Native peptide | Heteroclitic variant | Reference |
|---|---|---|
| Pigeon cytochrome c | Tobacco hornworm moth cytochrome c | (6) |
| CAP1; YLSGANLNL | CAP1-6D; YLSGADLNL | (4) |
| PLP 139-151; HSLGKWLGHPDDF | PLP 139-151, W144Q; HSLGKQLGHPDDF | (29) |
| MAGE-A6; IGHVYIFATCLGLSYD | MPFH2; IYIFAACL | (37) |
| IP-30 -11 to -3; LLDVPTAAV | HIV PR 76-84; LVGPTPVNI | (44) |
| HIV RT 309-317; ILKEPVHGV | HIV RT 309-317, I1Y; YLKEPVHGV | (42) |
| HIV RT 309-317; ILKEPVHGV | HIV RT 309-317, I1F; FLKEPVHGV | (42) |
| FR-18; QAPGKGLEWV | FR-18; QLPGKGLEWV | (13) |
| FR-9; TLFLQMNSL | FR-9; KLFLQMNSL | (50) |
| S598; RCQIFANI | S598, Q600Y; RCYIFANI | (72) |
| Melan-A EAAGIGILTV | Melan-A ELAGIGILTV | (28) |
Native peptides and heteroclitic variants cited as examples in the text are tabulated together with the corresponding reference. Although nomenclature used is not always standard, the peptide sequence is generally preceded by an abbreviation indicating the source and protein name followed by aa sequence coordinates within that protein, site, and identity of the relevant aa substitution in the heteroclitic variant and the peptide sequence. Altered amino acids within the heteroclitic variant are shown in bold text.